<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="19918">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01792011</url>
  </required_header>
  <id_info>
    <org_study_id>Institute of LLT</org_study_id>
    <nct_id>NCT01792011</nct_id>
  </id_info>
  <brief_title>Accuracy of the Pleth Variability Index to Predict Fluid Responsiveness in Liver Transplantation</brief_title>
  <official_title>Accuracy and Utility of the Pleth Variability Index as a Predictor of Fluid Responsiveness During the Dissection and Anhepatic Phase of Liver Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Inonu University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Inonu University</source>
  <oversight_info>
    <authority>Turkey: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare the accuracy of PVI (pleth variability index)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to compare the accuracy of PVI (pleth variability index)with other
      hemodynamic variability that measured with PÄ°CCO (SVV, PPV, CVP,CI)to predict the response
      of cardiac index to volume replacement in patients undergoing liver transplantation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Actual">February 2013</completion_date>
  <primary_completion_date type="Actual">February 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>To test the ability of PVI to detect changes in preload during orthotopic liver transplantation</measure>
    <time_frame>During dissection and anhepatic phase (3 months)</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>PVI is a measure of the dynamic changes in perfusion index that occur during a complete respiratory cycle</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Hemodynamic Instability</condition>
  <arm_group>
    <arm_group_label>PVI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A new non-invasive device (Radical-7 pulse oximeter monitor, Masimo Corp.) has been introduced that continuously detects changes in the plethysmograph waveform and computes a Plethysmography Variability Index (PVI) reflecting alteration in preload and fluid management.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PVI-guided fluid management</intervention_name>
    <description>In this study of 25 adult patients undergoing OLT, we prospectively record PVIwithin 5 minutes during dissection and anhepatic phase of OLT by Masimo pulse oximeter.In this study of 25 adult patients undergoing OLT, we prospectively record study data within 5 minutes during dissection and anhepatic phase of OLT. Study data included measurements of PVI,thermodilution cardiac output, Stroke volume variation (SVV) and Pulse pressure variation (PPV).</description>
    <arm_group_label>PVI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elective living donor liver transplantation,

          -  &gt;18 years patients

        Exclusion Criteria:

        Patients with:

          -  Arrhythmia

          -  Reduced left ventricular function (EF&lt;40%)

          -  Hepatocellular carcinoma

          -  Pulmonary hypertension

          -  Fulminant liver failure

          -  valvular heart disease
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gulay Erdogan Kayhan, Dr</last_name>
    <role>Study Chair</role>
    <affiliation>Inonu University Faculty of Medicine Anesthesiology and Reanimation Department</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Inonu University Faculty of Medicine Department of Anesthesiology and Reanimation</name>
      <address>
        <city>Malatya</city>
        <zip>44315</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <lastchanged_date>February 13, 2013</lastchanged_date>
  <firstreceived_date>February 8, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Inonu University</investigator_affiliation>
    <investigator_full_name>Gulay ERDOGAN KAYHAN</investigator_full_name>
    <investigator_title>MD,Asistant Professor Dr</investigator_title>
  </responsible_party>
  <keyword>Elective living donor liver transplantation</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
